Nanoparticles new hope for uterus cancer treatment



New York, Dec 5 (IANS) Tumour-targeting nanoparticles loaded with a drug that makes cancer cells more vulnerable to chemotherapy's toxicity can be a new approach in the treatment of endometrial cancer -- that begins in the uterus, researchers suggest.



Combining traditional chemotherapy with the relatively new cancer drug that attacks chemo-resistant tumour cells, the researchers packed both into tiny nanoparticles to create an extremely selective and lethal cancer treatment. 



The super-lethal nanoparticles reduced tumour growth and extended survival rates, a researcher said. 



"For the first time, we were able to combine two different tumour-targeting strategies and use them to defeat deadly Type II endometrial cancer. 



"We believe this treatment could be used to fight other cancers, as well," said lead researcher Kareem Ebeid, graduate student at the University of Iowa. 



In mice with Type II endometrial cancer, the team combined two anti-cancer drugs: paclitaxel, a type of chemotherapy used to treat endometrial cancer, and nintedanib, or BIBF 1120, a relatively new drug used to restrict tumour blood vessel growth. 



However, in the study published in the journal Nature Nanotechnology, nintedanib was used to target tumour cells with a specific mutation, known as Loss of Function p53 that interrupts the normal life cycle of tumour cells and makes them more resistant to the lethal effects of chemotherapy.



Paclitaxel chemotherapy killed cells when they were in the process of cell division, but tumour cells with the Loss of Function p53 mutation often slowed down this process, making cancer more resistant to the chemotherapy treatment. 



Nintedanib, on the other hand, attacked tumour cells with the mutation and compelled them to divide, a point at which they were easily killed by chemotherapy. 



"Basically, we are taking advantage of the tumour cells' Achilles heel--the Loss of Function mutation--and then sweeping in and killing them with chemotherapy," Ebeid said. 



The novel approach could also be used to treat other cancers as well, including types of ovarian and lung cancers that also carry the Loss of Function p53 mutation, he noted.

 

 

Related news

Don’t Miss

Sensex slips below 34k level, down 131 points in early trade
Goa assembly session to be cut short due to Parrikar's illness
This former top cricketer-turned-politician marries for the third time
Army foils infiltration bid, kills militant
4 killed in Russia church shooting
Both CPI-M, BJP confident of Tripura election victory
South Africa to bowl against India in 1st T20I
Another banking fraud out in the open, bring out white paper on banking system, says Congress
Successful NDA alliance due to roots of democracy in BJP: PM Modi
Trump slams FBI over Florida school shooting
Job seekers protest at Bihar railway stations
Moderate polling in Tripura Assembly elections
Iran plane crash: 66 people killed
Big B's interesting job application to work with Deepika, Katrina
BIG news: Maha to launch CHEAP sanitary pad scheme
Now, this company offering more DATA on postpaid plans
PNB case: Will take appropriate supervisory action, says RBI
This mobile company registered HUGE 217% growth in India
White House continues to deny Russia collusion
Florida school shooting survivors call for tougher gun laws
Uddhav tears into Modi, says make Nirav Modi RBI Governor
Islamic Iran supports India against Pak-bred terrorsism
Zabardast..Rekha salutes Asha Bhosle, touches feet..PICS
Modi in action..Rs 56740000000 worth Nirav 'maal' seized
Breaking: Top level involvement of Modi Govt in Nirav scam:Rahul
CVC summons PNB, Fin Min officials for Nirav Modi scam
This film gets Rs 70000000 opening in India
Rekha hints at broken heart.. Touches Asha Tai's feet
Nokia 6 at throwaway price.. RUSH
Pakistan minor's killer gets four death sentences

Most Recent




Most Popular